Virtu KCG Holdings’s Perspective Therapeutics CATX Stock Holding History

Virtu KCG Holdings’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$25K	Buy	+4,013	New	+$22.7K	﹤0.01%	2700
2017 Q1	–	Sell	-9,116	Closed	-$53K	–	3167
2016 Q4	$53K	Buy	+9,116	New	+$55.8K	﹤0.01%	3075
2016 Q3	–	Sell	-4,937	Closed	-$43K	–	3090
2016 Q2	$43K	Sell	4,937 -623	-11%	-$5.96K	﹤0.01%	2705
2016 Q1	$50K	Sell	5,560 -201	-3%	-$1.58K	﹤0.01%	2459
2015 Q4	$54K	Buy	5,761 +3,341	+138%	+$41.6K	﹤0.01%	3139
2015 Q3	$34K	Sell	2,420 -2,307	-49%	-$33.3K	﹤0.01%	3076
2015 Q2	$70K	Buy	4,727 +377	+9%	+$6.11K	﹤0.01%	3007
2015 Q1	$68K	Sell	4,350 -6,597	-60%	-$97.9K	﹤0.01%	2748
2014 Q4	$160K	Sell	10,947 -2,854	-21%	-$45.2K	﹤0.01%	3016
2014 Q3	$233K	Buy	+13,801	New	+$341K	﹤0.01%	2711
2014 Q2	–	Sell	-3,563	Closed	-$78K	–	3667
2014 Q1	$78K	Buy	+3,563	New	+$36.3K	﹤0.01%	3263

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CAG

Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

IFS

Ifrah Financial Services Little Rock, Arkansas $378M AUM 17.57% 1-Year Est. Return

Virtu KCG Holdings's CATX Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Perspective Therapeutics (CATX) in Q2 2017: 4,013 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #2700 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in CATX as recently as Q4 2016.

Virtu KCG Holdings first reported a position in CATX in Q1 2014 and has held it in 11 quarters since. The position peaked at $233K in Q3 2014. 27 funds tracked by Wall St. Rank hold CATX as of Q2 2017.

Virtu KCG Holdings held 4,013 shares of Perspective Therapeutics worth $25K as of Q2 2017.
Perspective Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
Perspective Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2700 holding.
Virtu KCG Holdings first reported a position in Perspective Therapeutics in Q1 2014 and has held it in 11 quarters since.
Virtu KCG Holdings's Perspective Therapeutics position peaked at $233K in Q3 2014.
27 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.